APA (7th ed.) Citation

M, D., F, G., H, B., A, T., H, S., A, L., . . . F, D. (2022). Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer. The Lancet. Child & adolescent health, 6(4), 260. https://doi.org/10.1016/S2352-4642(21)00337-0

Chicago Style (17th ed.) Citation

M, Delebarre, et al. "Decision-tree Derivation and External Validation of a New Clinical Decision Rule (DISCERN-FN) to Predict the Risk of Severe Infection During Febrile Neutropenia in Children Treated for Cancer." The Lancet. Child & Adolescent Health 6, no. 4 (2022): 260. https://doi.org/10.1016/S2352-4642(21)00337-0.

MLA (9th ed.) Citation

M, Delebarre, et al. "Decision-tree Derivation and External Validation of a New Clinical Decision Rule (DISCERN-FN) to Predict the Risk of Severe Infection During Febrile Neutropenia in Children Treated for Cancer." The Lancet. Child & Adolescent Health, vol. 6, no. 4, 2022, p. 260, https://doi.org/10.1016/S2352-4642(21)00337-0.